A novel target of mizoribine inhibiting mesangial cell proliferation: S phase kinase-associated protein 2

American Journal of Nephrology

Volumn 32, Issue 5, 2010, Pages 447-455

  Liu, Shuxin ^a,b   Xie, Yuansheng ^a   Lv, Yang ^a   Qin, Fufang ^a   Fu, Bo ^a   Shi, Suozhu ^a   Yin, Zhong ^a   Hong, Quan ^a   Zhang, Xueguang ^a   Wang, Jianzhong ^a   Chang, Ming ^b   Chen, Xiangmei ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b DALIAN MUNICIPAL CENTRAL HOSPITAL   (China)

Author keywords

Cell cycle proteins; Mesangial cell proliferation; Mizoribine; S phase kinase associated protein 2

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1B; MIZORIBINE; S PHASE KINASE ASSOCIATED PROTEIN 2;

ANIMAL CELL CULTURE; ANIMAL TISSUE; ARTICLE; CELL CYCLE REGULATION; CELL NUCLEUS; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS; DNA SYNTHESIS INHIBITION; DRUG MECHANISM; DRUG TARGETING; GENE OVEREXPRESSION; MALE; MESANGIUM CELL; MITOSIS INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT;

ANIMALS; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN D1; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DOWN-REGULATION; MESANGIAL CELLS; RATS; RIBONUCLEOSIDES; RNA, MESSENGER; S-PHASE KINASE-ASSOCIATED PROTEINS;

EID: 77957316706     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320334     Document Type: Article

References (21)

1. Cove-Smith A, Hendry BM: The regulation of mesangial cell proliferation. Nephron Exp Nephrol 2008;108: e74 - e79.
2. Shankland SJ, Hugo C, Coats SR, Nangaku M, Pichler RH, Gordon KL, Pippin J, Roberts JM, Couser WG, Johnson RJ: Changes in cell-cycle protein expression during experimental mesangial proliferative glomerulonephritis. Kidney Int 1996;50:1230-1239.
3. kip1 safeguards against inflammatory injury. Nat Med 1998;4:575-580.
4. kip1. J Am Soc Nephrol 1998;9:2235-2243.
5. Kanasaki K, Haneda M, Sugimoto T, Shibuya K, Isono M, Isshiki K, Araki S, Uzu T, Kashiwagi A, Koya D: N-acetyl-seryl-aspartyl-lysyl-proline inhibits DNA synthesis in human MC via up-regulation of cell cycle modulators. Biochem Biophys Res Commun 2006;342:758-765.
6. Mizuno K, Tsujino M, Takada M, Hayashi M, Atsumi K: Studies on bredinin. I. Isolation, characterization and biological properties. J Antibiot (Tokyo) 1974;27:775-782.
7. Turka LA, Dayton J, Sinclair G, Thompson CB, Mitchell BS: Guanine ribonucleotide depletion inhibits T-cell activation. Mechanism of action of the immunosuppressive drug mizoribine. J Clin Invest 1991;87:940-948.
8. Inou T, Kusaba R, Takahashi I, Sugimoto H, Kuzuhara K, Yamada Y, Yamauchi J, Otsubo O: Clinical trial of bredinin in renal transplantation. Transplant Proc 1981;13:315-318.
9. Kawasaki Y, Suzuki J, Sakai N, Etoh S, Murai H, Nozawa R, Suzuki H: Efficacy of prednisolone and mizoribine therapy for diffuse IgA nephropathy. Am J Nephrol 2004;24:147-153.
10. Yumura W, Suganuma S, Uchida K, Moriyama T, Otsubo S, Takei T, Naito M, Koike M, Nitta K, Nihei H: Effects of long-term treatment with mizoribine in patients with proliferative lupus nephritis. Clin Nephrol 2005;64:28-34.
11. Zhang X, Chen X, Wu D, Liu W, Wang J, Feng Z, Cai G, Fu B, Hong Q, Du J: Downregulation of connexin-43 expression by high glucose induces senescence in glomerular MC. J Am Soc Nephrol 2006;17:1532-1542.
12. Metz S, Holland S, Johnson L, Espling E, Rabaglia M, Segu V, Brockenbrough JS, Tran PO: Inosine 5′-monophosphate dehydrogenase is required for mitogenic competence of transformed pancreatic β cells. Endocrinology 2001;142:193-204.
13. Zimmermann AG, Gu JJ, Laliberte J, Mitchell BS: Inosine 5′-monophosphate dehydrogenase: regulation of expression and role in cellular proliferation and T-lymphocyte activation. Prog Nucleic Acid Res Mol Biol 1998;61:181-209.
14. Carrano AC, Eytan E, Hershko A, Pagano M: SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1999;1:193-199.
15. kip1. Biochem Biophys Res Commun 2001;282:853-860.
16. kip1, polyploidy and centrosome overduplication. EMBO J 2000;19:2069-2081.
17. Hershko DD: Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer. Cancer 2008;112:1415-1424.
18. Wu YJ, Bond M, Sala-Newby GB, Newby AC: Altered S-phase kinase-associated protein-2 levels are a major mediator of cyclic nucleotide-induced inhibition of vascular smooth muscle cell proliferation. Circ Res 2006;98:1141-1150.
19. Wu YJ, Sala-Newby GB, Shu KT, Yeh HI, Nakayama KI, Nakayama K, Newby AC, Bond M: S-phase kinase-associated protein-2 (Skp2) promotes vascular smooth muscle cell proliferation and neointima formation in vivo. J Vasc Surg 2009;50:1135-1142.
20. Zhong L, Georgia S, Tschen SI, Nakayama K, Nakayama K, Bhushan A: Essential role of Skp2-mediated p27 degradation in growth and adaptive expansion of pancreatic β cells. J Clin Invest 2007;117:2869-2876.
21. Suzuki S, Fukasawa H, Kitagawa K, Uchida C, Hattori T, Isobe T, Oda T, Misaki T, Ohashi N, Nakayama K, Nakayama KI, Hishida A, Yamamoto T, Kitagawa M: Renal damage in obstructive nephropathy is decreased in Skp2-deficient mice. Am J Pathol 2007;171:473-483.